Midatech Pharma PLC (MTP.OQ)
MTP.OQ on NASDAQ Stock Exchange Capital Market
0.74USD
25 Apr 2018
0.74USD
25 Apr 2018
Change (% chg)
$-0.01 (-1.33%)
$-0.01 (-1.33%)
Prev Close
$0.75
$0.75
Open
$0.75
$0.75
Day's High
$0.75
$0.75
Day's Low
$0.74
$0.74
Volume
140
140
Avg. Vol
18,054
18,054
52-wk High
$3.18
$3.18
52-wk Low
$0.74
$0.74
Select another date:
Wed, Feb 28 2018
BRIEF-Midatech Gets Orphan Drug Designation For Mtd119
* MIDATECH GETS ORPHAN DRUG DESIGNATION FOR MTD119 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)
BRIEF-Midatech Pharma Says Approval Of Investigational New Drug Application From US FDA To Conduct Study Of MTX110
* APPROVAL OF INVESTIGATIONAL NEW DRUG APPLICATION FROM US FDA TO CONDUCT A STUDY OF MTX110
BRIEF-Midatech Pharma Enters Into Four-Year Senior Secured Loan Agreement With Midcap Financial Of Up To $15 Mln
* MIDATECH PHARMA PLC - HAS ENTERED INTO A FOUR-YEAR SENIOR SECURED LOAN AGREEMENT WITH MIDCAP FINANCIAL OF UP TO $15 MILLION Source text for Eikon: Further company coverage:
BRIEF-Midatech Pharma U.S. Initiates Gelclair Phase IV Trial To Study Oral Mucositis In Stem Cell Transplant Patients
* MIDATECH PHARMA US INITIATES GELCLAIR® PHASE IV TRIAL TO STUDY ORAL MUCOSITIS IN STEM CELL TRANSPLANT PATIENTS
Select another date:
- Midatech Pharma PLC 2017 Q4 - Results - Earnings Call Slides
- 3 Things In Biotech You Should Learn Today: March 1, 2018
- Wall Street Breakfast: Tesla Gears Up For Model 3
- Midatech Is Something To Keep An Eye On
- Brexit Has Thrown Up Some UK ADR Bargains For The Long-Term Investor
- Oral Insulin Could Be Fools' Gold